England 2002

The First UK NETwork Conference on Neuroendocrine Tumours
Thursday 21st March, 2002
              International Convention Centre
Birmingham, ENGLAND

For physicians and nurses (CME APPROVAL APPLIED FOR)
               Please also see the web page for this conference at:   http://www.uk-network.org.uk/invitation.html

For registration and further information, please contact Maria Jones on tel.01753 627777 or fax 01753 627778
     (for International calls use country code 44)
      or email either: "Living With Carcinoid" Support group* co-chairpersons:
          Peter at peter.gwilliam@lineone.net
          Ted at tedbaill@aol.com
         * This group is working on their web page and hope to have it up on-line before this conference.

Programme Thursday 21 March 2002. Birmingham International Convention Centre
Registration & Coffee 0830-0930
0930-0950 Introduction and UK NETwork Overview – Dr Caplin (Chairman UK NETwork)

1. Session Chairman: Prof Bax & Prof Dhillon
0950-1010 Overview of Epidemiology of carcinoid tumours & pancreatic NETs – Mr Sutton
1010-1030 Genetics of NETS – Prof Thakker
1030-1050 Histopathology of Neuroendocrine Tumours – Dr McNicol
1050-1110 Overview of Quality of Life for NET patients – Dr Ramage
1110-1125 Panel Discussion – all participants of session 1
1125-1140 Coffee

2. Session Chairman: Prof Buchanan & Dr Peros
1140-1200 Biochemical investigation of NETs – Dr Ardill
1200-1220 Radiological Imaging for neuroendocrine tumours – Dr Jackson
1220-1240 Nuclear Medicine Imaging for neuroendocrine tumours – Dr Lewington
1240-1255 Panel Discussion - all participants of session 2

3. Session Chairman: Prof Hawkins & Prof Scanlon
1400-1420 Symptomatic treatment of neuroendocrine tumours – Dr Meeran
1420-1440 Chemotherapy and biotherapy for neuroendocrine tumours – Dr Read
1440-1500 Interventional Radiology for neuroendocrine tumours – Dr Watkinson
1500-1515 Panel Discussion – all participants of session 3
1515-1530 Tea

4. Session Chairman: Mr Buckels & Mr Kurzawinski
1530-1550 Radionuclide Targeted Therapy for neuroendocrine tumours – Prof Britton
1550-1610 Surgery for neuroendocrine tumours – Prof Neoptolomos
1610-1630 New treatments – Prof Steward
1630-1645 Panel Discussion - all participants of session 4
1645-1700 The Future for Management of Neuroendocrine Tumours – Dr Caplin

5. 1800-20.30 Evening Meeting - Patient Support Group:
Brief Overview of Carcinoid and Pancreatic NETs – Dr Caplin + ?
Any Questions – panel